Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Stud Health Technol Inform ; 52 Pt 2: 1265-8, 1998.
Article in English | MEDLINE | ID: mdl-10384662

ABSTRACT

Individuals must increasingly take control of managing their own health affairs. This requires access to quality information that is not easily obtained from traditional social institutions. NetWellness is an electronic consumer health information service that provides a model for reaching the goal of enhancing personal health and quality of life. [1] We present a vision of consumer health information delivery in the 21st century, and a model for reaching that vision. Our experience to date, progressing through a five-phase model, is aimed at providing the best health information possible to the widest population possible.


Subject(s)
Computer Communication Networks , Health Promotion , Information Services , Community Participation , Health Promotion/methods , Humans , Internet , Models, Theoretical
2.
J Am Med Inform Assoc ; 4(1): 6-13, 1997.
Article in English | MEDLINE | ID: mdl-8988468

ABSTRACT

The growing public interest in health and wellness information stems from many sources, including social changes related to consumers' rights and women's health movements, and economic changes brought about by the managed health care revolution. Public, hospital, and medical center libraries have been ill-equipped to meet the increasing need for consumer-oriented materials, even though a few notable programs have been established. The "Information Superhighway" could be an effective tool for sharing health information if access to telecomputing equipment and training were available to those with an information need. The University of Cincinnati Medical Center, with its libraries in the leading role, is delivering NetWellness, an electronic consumer health library service, to residents of 29 counties in three midwestern states. Users connect directly through the Internet, through regional Free-Nets, and by visiting one of 43 public access sites where networked workstations have been installed. The continued success of the project depends on developing partnerships, providing quality content and maintaining fair access.


Subject(s)
Computer Communication Networks , Health Education/methods , Information Services/organization & administration , Libraries, Medical , Community-Institutional Relations , Computer User Training , Computers , Humans , Ohio , Program Development , Program Evaluation , Quality Control , Software Design
3.
DICP ; 24(10): 976-81, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2244412

ABSTRACT

Although benzodiazepines have been proven safe and effective for the induction and maintenance of sedation, some instances require the reversal of these events prior to the natural process of metabolism and elimination. Flumazenil, a 1,4-imidazobenzodiazepine, is an antagonist that can reduce or terminate benzodiazepine effects in a dose-dependent manner. The antagonist acts by the competitive inhibition of benzodiazepines at their central nervous system receptor sites. When administered intravenously in incremental doses, flumazenil allows for optimal patient response on an individual basis. Despite its short elimination half-life, small doses of flumazenil are usually effective in producing benzodiazepine reversal. Flumazenil's short duration of activity is due to its rapid hepatic metabolism and elimination. Intravenous antagonist doses of 0.2 mg followed by 0.1 mg/min to a total dose of 1 mg have produced significant results in reversing benzodiazepine sedation. As much as 5 mg of flumazenil have been necessary when treating benzodiazepine or mixed-agent intoxications. In such situations, response rarely exceeds a duration of one hour. If resedation occurs, additional doses or an infusion of the antagonist may provide the desired response. Flumazenil is well tolerated locally as well as systemically. Nausea and vomiting occurring after anesthesia is the most documented adverse effect in both placebo and treatment populations. However, there has been no significant difference in the occurrence of vomiting in placebo compared with flumazenil-treated subjects. Careful observation and slow reversal of central nervous system depression is crucial in the avoidance of benzodiazepine withdrawal in those patients dependent upon these agents. Flumazenil appears to provide a mechanism for the safe and effective reversal of benzodiazepine-induced sedation.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Benzodiazepines/antagonists & inhibitors , Flumazenil/pharmacology , Anesthesia, General , Benzodiazepines/poisoning , Cerebrovascular Circulation , Drug Overdose/chemically induced , Flumazenil/administration & dosage , Flumazenil/adverse effects , Flumazenil/pharmacokinetics , Half-Life , Humans , Injections, Intravenous , Metabolic Clearance Rate , Time Factors
4.
Drug Inf J ; 21(2): 201-8, 1987.
Article in English | MEDLINE | ID: mdl-10282115

ABSTRACT

Heightened concern about drug abuse during the late 1960s prompted community leaders to request that the University of Cincinnati's Drug Information Center extend its services to the public. More than 500,000 inquiries have been handled by the Center since it first offered these services. The Center's "hotline" provides information, advice, counseling, and/or emergency treatment and referral information and is extensively involved in community outreach and prevention efforts. Providing reliable, authoritative, and beneficial information requires that all staff be professionally qualified and receive extensive training, pass specialized certification tests, follow structured policies and guidelines, and effectively use consultants. Impressions of the roles, impact, and need for such services in the 1980s are discussed.


Subject(s)
Community Participation , Drug Information Services , Poison Control Centers , Ohio , Self Medication
SELECTION OF CITATIONS
SEARCH DETAIL
...